Post Content
Veeva Systems Inc (NYSE:VEEV) is among the best medical AI stocks to buy now. Wall Street is taking note of Veeva’s AI efforts, and many believe the company is moving in the right direction. On April 1, Stifel reaffirmed its Buy rating and $245 price target on Veeva Systems stock, citing the company’s AI opportunities.
Copyright: nexusplexus / 123RF Stock Photo
Stifel renewed its bullish stance on Veeva stock after finding out that Veeva is a preferred vendor in the life sciences CRM space. The firm came to this conclusion following discussions with industry participants.
The findings showed that large pharmaceutical companies want to work with technology partners to weave AI capabilities into their platforms rather than doing it on their own. Stifel noted from the calls that even an existing Salesforce CRM customer was open to switching to a different provider.
It has embedded AI agents and AI shortcuts into its platform to help companies automate tasks and improve workforce productivity. To further build its AI capabilities, Veeva Systems announced on March 10 that it has acquired Ostro.
Ostro provides an AI-powered patient-doctor chat platform that delivers quick and 100% compliant responses. Veeva bought Ostro for around $100 million in cash and equity. Ostro will initially operate as a standalone unit but over time it will be integrated into Veeva to ensure a seamless workflow.
Veeva posted Q4 2025 financial results that exceeded expectations. Revenue rose 16% YoY to $836 million and surpassed the consensus estimate of $810.67 million. EPS of $2.06 topped the forecast of $1.93.
Veeva Systems Inc (NYSE:VEEV), founded in 2007 and based in California, provides cloud software, data, and analytics to the life sciences industry. Its solutions help drug and medical device companies to develop, test, and market their products faster and more efficiently. Veeva Systems customers include Bayer, Eli Lilly, Gilead Sciences, and Merck.
While we acknowledge the potential of VEEV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: David Abrams’ Hedge Fund Is Betting On These 8 Stocks and 10 Best Energy Storage Stocks to Buy According to Hedge Funds.
Disclosure: None. Follow Insider Monkey on Google News.